Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinming Song

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
Human Pathology|July 6, 2024
Clinicopathologic features and outcomes of acute leukemia harboring PICALM::MLLT10 fusionJeffrey Wang, Weiwei Zhang, Xinjie Xu, et al.
Human Pathology|March 23, 2023
Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement-A 10-case study and literature reviewLing Zhang, Bijal Shah, Yumeng Zhang, et al.
Leukemia & Lymphoma|February 25, 2020
Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated <i>RUNX1</i> versus acute myeloid leukemia with myelodysplasia-related changes with mutated <i>RUNX1</i>Lynh Nguyen, Xiaohui Zhang, Evans Roberts, et al.
Annals of Hematology|July 2, 2026
Impact of race on mutational profile and survival in acute myeloid leukemia: a single-institution experience (2014-2024)Utsav Joshi, Fatima Tuz Zahra, Pujan Patel, et al.
Blood Advances|January 3, 2024
Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AMLOnyee Chan, Najla Al Ali, Hammad Tashkandi, et al.
Cancer Research|April 13, 2017
An <i>Ex Vivo</i> Platform for the Prediction of Clinical Response in Multiple MyelomaAriosto Silva, Maria C Silva, Praneeth Sudalagunta, et al.
Cardio-Oncology (London, England)|May 9, 2026
Real-world prevalence and outcome of elevated right ventricular systolic pressure in myelofibrosisAlexis Behne Sharma, Elicia Wang, Sruthi Selvakumar, et al.
Blood|September 22, 2025
Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapyMark B Meads, Xiaohong Zhao, David R Noyes, et al.
Frontiers in Immunology|December 3, 2025
Case Report: Durable response to tumor-infiltrating lymphocyte therapy in a patient with metastatic melanoma and chronic lymphocytic leukemia/small lymphocytic lymphomaLilit Karapetyan, Joel Kuriakose, Matthew C Perez, et al.
Blood Cancer Journal|October 16, 2024
Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myelomaGliceida Galarza Fortuna, Rahul Banerjee, Constanza Savid-Frontera, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Human Pathology|July 6, 2024
Clinicopathologic features and outcomes of acute leukemia harboring PICALM::MLLT10 fusionJeffrey Wang, Weiwei Zhang, Xinjie Xu, et al.
Human Pathology|March 23, 2023
Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement-A 10-case study and literature reviewLing Zhang, Bijal Shah, Yumeng Zhang, et al.
Leukemia & Lymphoma|February 25, 2020
Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated <i>RUNX1</i> versus acute myeloid leukemia with myelodysplasia-related changes with mutated <i>RUNX1</i>Lynh Nguyen, Xiaohui Zhang, Evans Roberts, et al.
Annals of Hematology|July 2, 2026
Impact of race on mutational profile and survival in acute myeloid leukemia: a single-institution experience (2014-2024)Utsav Joshi, Fatima Tuz Zahra, Pujan Patel, et al.
Blood Advances|January 3, 2024
Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AMLOnyee Chan, Najla Al Ali, Hammad Tashkandi, et al.
Cancer Research|April 13, 2017
An <i>Ex Vivo</i> Platform for the Prediction of Clinical Response in Multiple MyelomaAriosto Silva, Maria C Silva, Praneeth Sudalagunta, et al.
Cardio-Oncology (London, England)|May 9, 2026
Real-world prevalence and outcome of elevated right ventricular systolic pressure in myelofibrosisAlexis Behne Sharma, Elicia Wang, Sruthi Selvakumar, et al.
Blood|September 22, 2025
Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapyMark B Meads, Xiaohong Zhao, David R Noyes, et al.
Frontiers in Immunology|December 3, 2025
Case Report: Durable response to tumor-infiltrating lymphocyte therapy in a patient with metastatic melanoma and chronic lymphocytic leukemia/small lymphocytic lymphomaLilit Karapetyan, Joel Kuriakose, Matthew C Perez, et al.
Blood Cancer Journal|October 16, 2024
Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myelomaGliceida Galarza Fortuna, Rahul Banerjee, Constanza Savid-Frontera, et al.
Pageof 18